Status:
UNKNOWN
Management of an Imipenem-resistant Acinetobacter Baumannii Alert in a French University Hospital
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Acinetobacter Baumannii
Eligibility:
All Genders
18+ years
Brief Summary
Colonization with imipenem-resistant Acinetobacter baumannii (IBA) is an unfavorable event for the patient, especially in intensive care. Indeed, it exposes the patient to the risk of developing serio...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Major subject (≥18 years old)
- Patient having been hospitalized in the surgical resuscitation service of Hautepierre during the ABRI epidemic, between 01/05/2015 and 01/01/2019 inclusive and having been colonized and/or infected by ABRI (according to bacteriological results transmitted to the hygiene service).
- Subject having given his/her agreement, after information, for the reuse of his/her data for the purpose of this research
- Exclusion criteria:
- Subject having expressed his opposition to participate in the study
- Subject under guardianship or curatorship
- Subject under legal protection
Exclusion
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT06173440
Start Date
January 1 2020
End Date
December 1 2023
Last Update
December 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service Equipe opérationnelle d'hygiène - CHU de Strasbourg - France
Strasbourg, France, 67091